Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions.
Casareto L, Appelman-Dijkstra NM, Brandi ML, Chapurlat R, Cormier-Daire V, Hamdy NAT, Heath KE, Horn J, Mantovani G, Mohnike K, Sousa SB, Travessa A, Wekre LL, Zillikens MC, Sangiorgi L; European Reference Network on rare BONe Diseases. Casareto L, et al. Among authors: mohnike k. Eur J Med Genet. 2024 Apr;68:104916. doi: 10.1016/j.ejmg.2024.104916. Epub 2024 Feb 1. Eur J Med Genet. 2024. PMID: 38296035 Free article.
European Achondroplasia Forum Practical Considerations for Following Adults with Achondroplasia.
Fredwall S, AlSayed M, Ben-Omran T, Boero S, Cormier-Daire V, Fauroux B, Guillén-Navarro E, Innig F, Kunkel P, Lampe C, Maghnie M, Mohnike K, Mortier G, Pejin Z, Sessa M, Sousa SB, Irving M. Fredwall S, et al. Among authors: mohnike k. Adv Ther. 2024 Jul;41(7):2545-2558. doi: 10.1007/s12325-024-02880-3. Epub 2024 May 15. Adv Ther. 2024. PMID: 38748332 Free PMC article.
International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia.
Savarirayan R, Hoover-Fong J, Ozono K, Backeljauw P, Cormier-Daire V, DeAndrade K, Ireland P, Irving M, Llerena Junior J, Maghnie M, Menzel M, Merchant N, Mohnike K, Iruretagoyena SN, Okada K, Fredwall SO. Savarirayan R, et al. Among authors: mohnike k. Nat Rev Endocrinol. 2025 Jan 6. doi: 10.1038/s41574-024-01074-9. Online ahead of print. Nat Rev Endocrinol. 2025. PMID: 39757323 Review.
Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life.
Savarirayan R, Irving M, Wilcox WR, Bacino CA, Hoover-Fong JE, Harmatz P, Polgreen LE, Mohnike K, Prada CE, Kubota T, Arundel P, Leiva-Gea A, Rowell R, Low A, Sabir I, Huntsman-Labed A, Day J. Savarirayan R, et al. Among authors: mohnike k. Genet Med. 2024 Dec;26(12):101274. doi: 10.1016/j.gim.2024.101274. Epub 2024 Sep 18. Genet Med. 2024. PMID: 39305160 Free article. Clinical Trial.
Editorial: The problem of childhood hypoglycemia, volume II.
Banerjee I, Mohnike K. Banerjee I, et al. Among authors: mohnike k. Front Endocrinol (Lausanne). 2024 Apr 29;15:1412976. doi: 10.3389/fendo.2024.1412976. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38742203 Free PMC article. No abstract available.
Development of a Weight-Band Dosing Approach for Vosoritide in Children with Achondroplasia Using a Population Pharmacokinetic Model.
Qi Y, Chan ML, Mould DR, Larimore K, Fisheleva E, Cherukuri A, Day J, Savarirayan R, Irving M, Bacino CA, Hoover-Fong J, Ozono K, Mohnike K, Wilcox WR, Bober MB, Henshaw J. Qi Y, et al. Among authors: mohnike k. Clin Pharmacokinet. 2024 May;63(5):707-719. doi: 10.1007/s40262-024-01371-6. Epub 2024 Apr 23. Clin Pharmacokinet. 2024. PMID: 38649657 Free PMC article.
204 results